SARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner

Moe Kobayashi, Nene Kobayashi, Kyoka Deguchi, Seira Omori, Takeshi Ichinohe

Open source

DOI
10.1038/s41541-025-01095-z
Published
2025-02-27
Container
npj Vaccines
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41541-025-01095-z,
  title = {SARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner},
  author = {Moe Kobayashi and Nene Kobayashi and Kyoka Deguchi and Seira Omori and Takeshi Ichinohe},
  year = {2025},
  journal = {npj Vaccines},
  doi = {10.1038/s41541-025-01095-z},
  url = {https://doi.org/10.1038/s41541-025-01095-z}
}

RIS

TY  - JOUR
TI  - SARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner
AU  - Moe Kobayashi
AU  - Nene Kobayashi
AU  - Kyoka Deguchi
AU  - Seira Omori
AU  - Takeshi Ichinohe
PY  - 2025
JO  - npj Vaccines
DO  - 10.1038/s41541-025-01095-z
UR  - https://doi.org/10.1038/s41541-025-01095-z
ER  - 

APA

Kobayashi, M., Kobayashi, N., Deguchi, K., Omori, S., & Ichinohe, T. (2025). SARS-CoV-2 infection primes cross-protective respiratory IgA in a MyD88- and MAVS-dependent manner. npj Vaccines. https://doi.org/10.1038/s41541-025-01095-z

Source records